Clinical Trial Update: Adjunctive Treatment With L-methylfolate for Treatment-Resistant Generalized Anxiety Disorder: a Pilot Study [Phase 4]

View source ↗

Summary

Phase 4 pilot study evaluating adjunctive L-methylfolate for treatment-resistant generalized anxiety disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• L-methylfolate (L-methylfolate)

Snippet

Sponsor: Queen's University | Conditions: Generalized Anxiety Disorder | Phase 4 | Status: RECRUITING